Photocure Strengthens EMEA Leadership with Jane Healy

In a strategic move to bolster its presence in the European, Middle Eastern, and African (EMEA) region, Photocure ASA, the Bladder Cancer Company, has appointed Jane Healy as Vice President and General Manager EMEA. This appointment comes at a pivotal time for Photocure, as the company continues to innovate and expand its reach in the uro-oncology sector. Healy's extensive experience in the medical device field, coupled with her proven track record of driving growth and innovation, positions her as a key asset in achieving Photocure's ambitious goals.



Jane Healy brings over 30 years of experience in the medical device industry, having held leadership roles at St. Jude Medical, CR Bard, and Boston Scientific. Her most recent position as VP EMEA for the Peripheral Interventions Division at Boston Scientific has equipped her with a deep understanding of the European market and the skills necessary to drive growth strategies. Healy's commercial acumen, results orientation, and passion for enabling and driving results through her teams make her an ideal fit for leading Photocure's European Organization.

One of the key areas where Healy's expertise will be instrumental is in leveraging Blue Light Cystoscopy (BLC) technology. Photocure's European Organization was launched following the agreement to regain the Hexvix® sales, marketing, and distribution rights in Europe and other markets from Ipsen Pharma SAS on October 1, 2020. Since then, the European team has gained momentum by re-introducing BLC to the European market. Healy's leadership will be crucial in continuing this momentum and emphasizing the importance of BLC in the precision diagnostic pathway for bladder cancer. Accurate staging and resection are essential for determining the optimal treatment decisions, and Healy's strategic vision will help Photocure maintain its competitive edge in this area.

Healy's multilingual capabilities, speaking English, French, German, and Italian, will also be beneficial in communicating with stakeholders and customers across different European countries. This linguistic and cultural proficiency will enable her to build strong relationships and drive Photocure's growth in the region. Her ability to navigate diverse organizational structures and cultures, combined with her strategic leadership skills, will be instrumental in achieving Photocure's growth ambitions in uro-oncology.

In summary, Jane Healy's appointment as Vice President and General Manager EMEA is a strategic move that aligns with Photocure's mission to improve the lives of bladder cancer patients through innovative solutions. Her extensive experience, commercial acumen, multilingual capabilities, and track record of building successful international teams position her to drive growth and innovation for Photocure in the EMEA region. As Photocure continues to innovate and expand its reach, Healy's leadership will be crucial in achieving its ambitious goals and maintaining its competitive edge in the uro-oncology sector.